Elite Pharmaceuticals (ELTP) 10-K/A 31 Jul 23 2023 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Mar. 31, 2023	Jun. 20, 2023	Sep. 30, 2022
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	This Amendment No. 1 on Form 10-K/A (this “Amendment No. 1”) is being filed to amend our Annual Report on Form 10-K for the annual period ended March 31, 2023 (the “Original Filing”), filed with the U.S. Securities and Exchange Commission on June 29, 2023 (the “Original Filing Date”)
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--03-31
Entity File Number	001-15697
Entity Registrant Name	ELITE PHARMACEUTICALS, INC.
Entity Central Index Key	0001053369
Entity Tax Identification Number	22-3542636
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	165 LUDLOW AVENUE
Entity Address, City or Town	NORTHVALE
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07647
City Area Code	(201) 750-2646
Local Phone Number	750-2646
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	ELTP
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 40,556,603
Entity Common Stock, Shares Outstanding		1,013,915,081
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Name	Buchbinder Tunick & Company LLP
Auditor Location	Little Falls, New Jersey 07424
Auditor Firm ID	6189